← Back to Astal Laboratories Ltd Overview

📊Financials 📈PE Ratio 🥧Shareholding 💰Dividend 📋Quarterly ⚖️Balance Sheet 💹P&L 🌊Cash Flow

ASTALLTDPharmaceuticals

Astal Laboratories Ltd — Financial Ratios & Key Metrics

₹65.36

+0.94%

P/E Ratio9.61xIndustry: 31.77x

ROE30.10%Return on equity

ROCE34.78%Return on capital

Debt/Equity0.29Low debt

💎

Valuation & Profitability

P/E Ratio

9.61x

Industry Average P/E

31.77x

Dividend Yield

0.00%

Market Cap

₹95.11 (Cr)

Sales Growth 5Y

N/A

Profit Growth 5Y

212.84%

EPS Growth 5Y

161.53%

OPM 5Y Avg

15.05%

📉

Price Returns

1 Month

-7.76%

3 Months

+3.70%

6 Months

+6.24%

1 Year

-5.15%

52W Low

₹66

Current

₹65

52W High

₹103

-2% of 52-week range — Near lows

🔬

Technical Indicators

Neutral

Momentum is balanced — neither overbought nor oversold.

SMA 50

₹78

▼ Price below SMA 50 — Bearish

SMA 200

₹85

▼ Long-term downtrend

Volume Signal

82% of avg

Average volume

Technical indicators are for educational purposes only. Not investment advice.

More on Astal Laboratories Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.